Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow the growth of cancer cells.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed for early-stage breast cancer after surgery and for advanced breast cancer. The medication is designed to inhibit the enzyme aromatase, which plays a key role in estrogen production. This reduction in estrogen can help control the growth of cancer cells that rely on estrogen to proliferate.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users might experience nausea, dizziness, or increased sweating. These effects can vary in intensity and duration among individuals.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. Regular monitoring of bone density may be recommended due to the potential impact on bone health. It is important to follow the advice of a healthcare provider regarding the use of this medication.

Femara may interact with certain medications, including estrogen-containing therapies and some types of antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Femara.